Question 1

How should the infection model be chosen?

Accepted Answer

Match it to the claim. Immortalised cell lines give throughput and reproducibility but blunted responses. Primary phagocytes behave more realistically at the cost of donor variability. Whole animal work captures recruitment and tissue context but needs approvals and larger numbers. Most projects layer two models and treat agreement between them as the finding.

Question 2

Why does growth condition matter so much for surface recognition?

Accepted Answer

What sits on the outside is dynamic. Carbon source, medium richness, temperature, oxygen, and growth phase all shift wall architecture and how much of the recognised polysaccharide is exposed. Two laboratories using the same species can therefore report opposite recognition results. Record the growth history precisely and hold it constant across every comparison.

Question 3

How can fungal and host contributions be separated?

Accepted Answer

Manipulate both sides. Pair a fungal variant with blocking or genetic modification of the receptor pathway proposed, and confirm the fungal change has not affected growth rate or viability independently. If a phenotype disappears when the host pathway is disabled, the interaction is supported; if it persists, another route is operating.

Question 4

What controls belong in complement and serum assays?

Accepted Answer

Include heat-treated serum to remove complement activity while retaining other factors, a serum-free condition, and pooled versus individual donor serum where availability allows. Record storage time and freeze-thaw cycles, since activity declines quickly. Where regulator capture is claimed, show binding directly and show that removing the regulator restores deposition.

Question 5

How is survival inside phagocytes measured reliably?

Accepted Answer

Fluorescent signal persists in cells that are no longer viable, so imaging alone overstates survival. Combine time-lapse observation with recovery counts from lysed phagocytes and a viability stain read at the same points. Report the ingestion rate separately from the survival rate, because a variant taken up less often is not thereby better at surviving.

Question 6

How should donor variation in primary immune cells be handled?

Accepted Answer

Treat donors as the unit of replication, not wells. Variation between individuals in receptor expression and killing capacity commonly exceeds technical variation, so three wells from one donor do not constitute three replicates. Plan for several donors, record their basic characteristics where ethics allows, and use paired analysis across donors.

Question 7

Which containment and approval steps should be planned early?

Accepted Answer

Confirm the containment level required for each species and each procedure, since some work needs higher provision than routine culture. Animal work needs approval well before the intended start, and primary human cell work needs its own consent route. Building these timelines into the plan avoids a long idle period mid-candidature.

Microbiology

Microbiology

Research Frontiers in Fungal Immune Evasion and Host Adaptation